Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01032603 · ClinicalTrials.gov registry record · NA
Bilateral Lateral Rectus Recession Versus Unilateral Recess-Resect for Intermittent Exotropia
A NA study, sponsored by Jaeb Center for Health Research.
- Completed
- Registry status
- NA
- Development phase
- 197
- Enrollment target
NCT01032603: Completed NA study, sponsored by Jaeb Center for Health Research.
NCT01032603 is a NA study that has completed, run by Jaeb Center for Health Research. The registered enrollment target is 197 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01032603, a NA study, has completed, sponsored by Jaeb Center for Health Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 197 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of bilateral lateral rectus muscle recession versus unilateral lateral rectus recession with medial rectus resection procedures for the treatment of basic type and pseudo divergence excess type intermittent exotropia.
Primary Outcome
A participant's intermittent exotropia (IXT) was considered to be a suboptimal surgical outcome if at any visit occurring 6 months or later, ANY of the following criteria are present by masked examiner testing: 1. Exotropia at distance OR near at any time during the exam (i.e., can be constant or intermittent; determined by a cover/uncover test) with a magnitude of ≥10Δ by SPCT, confirmed by a retest 2. Constant esotropia at distance OR near (determined by at least 3 cover/uncover tests-one mus
Interventions
- PROCEDURE Bilateral lateral rectus recession (BLRc)
- PROCEDURE Unilateral lateral rectus recession with medial rectus resection (R&R)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 197 participants |
| Start Date | 2010-06-01 |
| Est. Completion | 2022-02-18 |
| Phase | NA |
What the finished NCT01032603 record still lists
NCT01032603 is an interventional study that assigns participants to a tested intervention. The registered 197 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 2 interventions - of which Bilateral lateral rectus recession (BLRc) is the first listed.
NCT01032603 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01032603 about?
NCT01032603 is a clinical study titled "Bilateral Lateral Rectus Recession Versus Unilateral Recess-Resect for Intermittent Exotropia". The purpose of this study is to evaluate the effectiveness of bilateral lateral rectus muscle recession versus unilateral lateral rectus recession with medial rectus resection procedures for the treatment of basic type and pseudo divergence excess type intermittent exotropia.
What is the current status of trial NCT01032603?
This trial is currently completed. It is a NA study. The enrollment target is 197 participants. The study started on 2010-06-01. Estimated completion is 2022-02-18.
What interventions are being tested in trial NCT01032603?
The interventions under investigation include: Bilateral lateral rectus recession (BLRc) (PROCEDURE), Unilateral lateral rectus recession with medial rectus resection (R&R) (PROCEDURE).
Who is sponsoring clinical trial NCT01032603?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01032603's enrollment target sits among peer trials
197 567th of 2000 higher than 1,434 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04219254 · 197 participants · Phase 1
A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
- NCT06173778 · 197 participants · Phase 2
Semaglutide for Post-Smoking Cessation Weight Management
- NCT05203328 · 198 participants · NA
Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy
- NCT05426967 · 198 participants · NA
rTMS for Military TBI-related Depression
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI